Skip to main content

Advertisement

Interventions to prevent, delay or reverse frailty in older people: a journey towards clinical guidelines

Article metrics

Abstract

Background

Age-related frailty is a multidimensional dynamic condition associated with adverse patient outcomes and high costs for health systems. Several interventions have been proposed to tackle frailty. This correspondence article describes the journey through the development of evidence- and consensus-based guidelines on interventions aimed at preventing, delaying or reversing frailty in the context of the FOCUS (Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input) project (664367-FOCUS-HP-PJ-2014). The rationale, framework, processes and content of the guidelines are described.

Main text

The guidelines were framed into four questions – one general and three on specific groups of interventions – all including frailty as the primary outcome of interest. Quantitative and qualitative studies and reviews conducted in the context of the FOCUS project represented the evidence base. We followed the GRADE Evidence-to-Decision frameworks based on assessment of whether the problem is a priority, the magnitude of the desirable and undesirable effects, the certainty of the evidence, stakeholders’ values, the balance between desirable and undesirable effects, the resource use, and other factors like acceptability and feasibility. Experts in the FOCUS consortium acted as panellists in the consensus process. Overall, we eventually recommended interventions intended to affect frailty as well as its course and related outcomes. Specifically, we recommended (1) physical activity programmes or nutritional interventions or a combination of both; (2) interventions based on tailored care and/or geriatric evaluation and management; and (3) interventions based on cognitive training (alone or in combination with exercise and nutritional supplementation). The panel did not support interventions based on hormone treatments or problem-solving therapy. However, all our recommendations were weak (provisional) due to the limited available evidence and based on heterogeneous studies of limited quality. Furthermore, they are conditional to the consideration of participant-, organisational- and contextual/cultural-related facilitators or barriers. There is insufficient evidence in favour of or against other types of interventions.

Conclusions

We provided guidelines based on quantitative and qualitative evidence, adopting methodological standards, and integrating relevant stakeholders’ inputs and perspectives. We identified the need for further studies of a higher methodological quality to explore interventions with the potential to affect frailty.

Background

Frailty and its impact

The term ‘frailty’ has been used to describe an age-related state of decline and vulnerability characterised by weakness and decreased physiological reserve [1]. Frail older adults are less able to adapt to stressors such as acute illness, surgery, trauma or bereavement, and are at increased risk of falls, institutionalisation, disability and death [2, 3]. The concept of frailty has been operationalised through different definitions to help clinicians, researchers and other stakeholders to identify frail older patients. One of the most commonly adopted definitions is the one used in the Cardiovascular Health Study, known as the Frailty Phenotype or Physical Frailty. It is based on five criteria related to reduced physical reserve, and defines frail and prefrail states based on the number of criteria met [1]. Others sustain a different approach, which views frailty as a multidimensional risk state defined by the accumulation of deficits in different domains, such as cognition and mood, chronic diseases, polypharmacy, functional autonomy and social conditions, using a continuous scale as opposed to category assignment. The Frailty Index by Rockwood et al. [4] is taken as a paradigm of this second approach.

Although the use of different definitions leads to the identification of different target populations and leads to a variation in the estimate of the actual prevalence of frailty [5, 6], the associations between frailty, adverse outcomes, and health and social care utilisation have been invariably demonstrated. This has been common understanding for more than a decade [7] and has led to several initiatives to tackle frailty and its related outcomes.

The FOCUS project

To add to the international efforts to reduce the impact of frailty, we conducted the FOCUS (Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input) project, funded by the European Union’s Third Health Programme (2014–2020) [8, 9]. The project included a series of quantitative and qualitative studies [10,11,12,13,14,15,16] (Table 1), which, through the review and appraisal of the literature and the collection of stakeholder inputs, served the project mission of providing instruments to guide the implementation and scaling up of effective strategies of frailty prevention and management. The development of clinical guidelines represented an ultimate important achievement in the fulfilment of this mission.

Table 1 The FOCUS evidence base and its relevance in the assessment of interventions targeting frailty based on the Evidence-to-Decision (EtD) criteria

The need for clinical guidelines

At the time of designing our project, we recognised the need to offer patients, their formal and informal carers, healthcare practitioners, and decision-makers a scientific support to their actions, by bringing together scientific evidence and stakeholder perspectives into recommendations that responded to the definition of clinical guidelines [17, 18]. In fact, as the interest in the concept of frailty had also grown outside the internal and geriatric medicine field, we had seen several non-geriatric scientific societies including special considerations on the management of the disease(s) of interest related to older frail patients in their clinical guidelines [19,20,21,22]. However, within the specific field of frailty as a syndrome, when the FOCUS consortium started its work in 2015, there were no clinical guidelines generated from rigorous methods recognised as standards by the scientific community, which would give frailty the dignity of other clinical conditions [23]. Therefore, we translated our FOCUS project mission into the development of evidence- and consensus-based guidelines, intended for all those involved in decision-making and implementation of actions on frailty.

This correspondence article presents the development process of our FOCUS guidelines, providing their justification, with emphasis on their novelty, limitations and implications.

Main text

Definition of the clinical questions: frailty as an outcome

We started by formulating the questions to be answered by the guidelines, based on the PICO format [24] (Table 2). While the project covered the entire spectrum of relevant clinical questions on frailty, including screening and diagnostic strategies [10], we decided to focus the guidelines on the role of interventions to prevent, delay or revert frailty. We framed the guidelines according to a hierarchical structure. We included a first question (General Question, GQ) asking whether the overall current evidence and stakeholder inputs support interventions meant to affect frailty and its course, followed by the addition of sub-questions (Questions 1–3 (Q1–Q3)) focused on specific types of interventions. For each question, two population subgroups were also considered, i.e. frail and prefrail subjects. The choice of the outcome and its definition represented the most sensitive step in the formulation of our PICO questions. We prespecified ‘frailty’ as our primary outcome, in compliance with the FOCUS project mission and the intention to treat frailty as a syndrome; we reflected the choice previously made in the definition of the study inclusion criteria for our systematic review of randomised controlled trials on interventions to prevent or reduce frailty [11]. Specifically, in our systematic review, we included studies that looked at the effect of interventions on frailty defined according to any validated scale, index, indicator or sets of indicators that were explicitly adopted by the authors as a definition for frailty [11]. However, our systematic review and guidelines also considered and evaluated the effect on frailty-related outcomes, which we defined as our secondary outcomes, including cognitive performance, ability to perform activities of daily life and quality of life, among others [11].

Table 2 FOCUS guideline questions in the PICO format

Selection of a framework: GRADE and Evidence-to-Decision

We adopted the GRADE (Grading of Recommendations Assessment, Development and Evaluation) Working Group system to assess the certainty of evidence and define the strength of related recommendations [25, 26]. In particular, we followed the Evidence-to-Decision (EtD) framework, which was developed by the GRADE Working Group to support the process of moving from evidence to decisions, in the contexts of making clinical recommendations or coverage, health system, or public health decisions [27]. It has been implemented as an interactive online tool (iEtD) that can support a consensus-based process, which we used [28]. The framework suggests a list of criteria upon which the intervention(s) of interest should be assessed based on research evidence, namely whether the problem is a priority, the magnitude of the desirable and undesirable effects, the certainty of the evidence, how patients (or others affected, such as carers) value the main outcomes, the balance between desirable and undesirable effects, resource use, acceptability, and feasibility [27].

FOCUS evidence base

The development of our guidelines was preceded by a series of quantitative and qualitative studies performed within the FOCUS project, reported in separate publications [11,12,13,14,15,16], which represented the evidence base for our judgments and recommendations. In particular, we performed a systematic review of randomised controlled trials evaluating interventions on frailty, which represented our quantitative evidence base [11]. As a support to the consensus process, the relevant results of the systematic review were synthesised into tables, one for each of the sub-questions (Additional file 1). The tables focused on the effect of interventions on frailty as an outcome, according to different frailty definitions and based on the typical GRADE Summary of Findings table structure [25]. The effect of interventions on the secondary outcomes was narratively synthesised (Additional file 2). We also performed a realist review [16], using the approach of the Realist and Meta-narrative Evidence Synthesis: Evolving Standards (RAMESES) project [29] and integrating the results of the systematic review with other FOCUS studies, to try to respond to the question “what works, for whom and in what circumstances’; this realist review represented the base for our recommendations on implementation (i.e. the conditions for the intervention to succeed). These and the other FOCUS studies are listed in Table 1, together with their relevance to the EtD criteria used to develop these guidelines.

Consensus process

The guideline panel included the FOCUS project investigators with a background in health and social sciences as well as expertise in frailty, aging and health research methods. Most of them are members of the European Innovation Partnership on Active and Healthy Ageing (EIP-AHA) [30]. Table S1 in the Additional file 3: Table S1 lists the FOCUS investigators, their professional profile and their role in guideline development. We undertook a multistep approach, as schematised in Fig. 1. The technical team (Table S1) conducted a preliminary appraisal of the evidence base upon the iEtD criteria and submitted it to the panel using the iEtD tool. The panel was asked to revise this appraisal and to make their judgment on the existing evidence for each question, upon each criterion. In particular, the judgement was guided by criterion-specific questions (e.g. ‘How substantial are the desirable anticipated effects?’) that the panel had to answer using an ordinal scale. Voting was anonymous. Panel discussion was also encouraged via email. The technical team collated the panel’s judgments and comments. A draft consensus judgement for each criterion and for each question was determined based on the mode and median rating. Any non-coincidence between mode and median rating was considered semi-quantitative proof of skewness of the votes, suggesting the need for discussion with the panel. Even when mode and median coincided, a note (e.g. ‘+’ or ‘–’) was added to the draft consensus statement in the case of significant heterogeneity in the vote distribution.

Fig. 1
figure1

Steps of the FOCUS guideline development process

Of the 13 FOCUS project investigators who were given the role of voting panellists, 11 participated in the voting process. All criteria for all questions were covered by the voting, but with a few missing votes, which were evenly distributed across criteria and questions. We provide an example of the voting outcome, based on the iEtD output and with the addition of the panel’s comments and technical team’s annotations (Additional file 4). The level of agreement was generally very good, but varied slightly across questions and criteria; it was higher for GQ (the highest) and Q1 compared with Q2 and Q3. Although initially all the EtD criteria were judged relevant for guideline development, the FOCUS panellists considered the existing evidence upon the criteria of resource use and cost-effectiveness, as collected in the frame of the FOCUS project, insufficient to use these criteria to justify their recommendations (Additional file 5). Subsequently, the main point raised by the panel during the discussion was the necessity to put more emphasis on what had been learned from the qualitative evidence base, and in particular from our realist review, which combined qualitative and quantitative evidence [16]. This translated into a final version in which the suggestions on how to implement interventions to increase the chance of success were included in the core of the guidelines, rather than only as additional considerations. Finally, the attribute of ‘conditional’ for recommendations, as opposed to ‘strong’, was preferred over ‘weak’ to emphasise that the recommendation is conditional to confirmation from further evidence and/or conditional to implementing facilitators or overcoming barriers.

FOCUS guidelines and their justification

Table 3 presents the final FOCUS Recommendations (R) on interventions to prevent or delay the progression of frailty, or to reverse frailty, in response to the four questions, i.e. RG (‘G’ for general), R1, R2, and R3. Below, we offer a justification, subgroup considerations and other considerations related to monitoring and evaluation, for each guideline. In Additional file 5 we provide a detailed justification for the judgement on each criterion for each guideline.

Table 3 FOCUS guidelines

RG – We suggest implementing interventions specifically intended to have an impact on frailty in older age, i.e. preventing or delaying the progression of frailty or reversing frailty (conditional strength of recommendation).

Justification.

The recommendation stems from the belief, common among different stakeholders and endorsed by the guideline panel, that frailty as an outcome is important and that interventions explicitly conceived to address it are needed. We found some quantitative evidence for different interventions being associated with delaying the progression of frailty or reverting frailty, although the effects were moderate in their size at maximum. These interventions, based on either a mainly physical concept of frailty or on a more comprehensive view, could be potentially fair, acceptable and feasible from a population perspective. However, the strength of this recommendation is weak/conditional because of the low certainty/quality of the quantitative evidence, due to substantial study limitations, inconsistency and heterogeneity across studies (different populations, interventions, outcome definition, and settings/contexts) as well as imprecision of the estimates.

Subgroup considerations.

The level or extent of frailty was expected to act as an effect modifier of interventions on frailty, i.e. affecting their relative effect, because of several reasons. For instance, some interventions are expected to work only or more in the presence of a certain deficit status. On the other hand, being frailer might affect the opportunity to benefit from interventions that either require an active participation or work only in less severe illness states. In fact, among the studies examined in our systematic review [11], those that found significant benefits on frailty progression included participants belonging to a range of levels of frailty and ages. It was difficult to look at the effect of the level of frailty as a predictor of an intervention to succeed since the heterogeneity across studies upon several aspects meant that the role of the level of frailty could have been confounded by other possible predictors such as the level of compliance or adherence to the intervention. Moreover, even if some of the authors themselves supposed or perceived there to be a window for the intervention to work according to the level of frailty or disability of participants, this hypothesis was not systematically explored in any study.

Considerations on monitoring and evaluation.

The panel judged the implementation of strategies to monitor (and then improve) the adherence to the intervention as important, in particular in the case of interventions that require an active participation of the older person. The need to implement an effective evaluation plan of the interventions was also emphasised. In the FOCUS project, we aimed to analyse the initiatives (i.e. commitments or Good Practices) within the EIP-AHA [30] in order to study the relationship between the outcomes of these initiative and feasibility aspects (barriers and facilitators), resources and processes (Table 1). In this context, we found that many initiatives were undertaken without any plan for evaluation, e.g. assessment of their outcomes in the long run, outside of a research context, and/or compared with the resources used. This limits the opportunity to assess the transferability and scalability of interventions, which is important from a population perspective, and is one of the main objectives of the EIP-AHA initiative of the European Commission.

R1 – We suggest implementing physical interventions, including physical activity/exercise, nutritional interventions, and a combination of exercise and nutritional interventions, to prevent or delay the progression of frailty or to reverse frailty (conditional strength of recommendation). The recommendation is stronger for group-based supervised exercise programmes, either alone or in association with nutritional supplementation.

Justification.

We found quantitative evidence supporting the success of physical interventions in delaying the progression of or revert frailty, especially when frailty was defined according to a physical paradigm or measures of its physical component. This component, according to older people’s opinions collected through our qualitative studies (Table 1), although partial, appears to have a compensatory and synergistic relationship with other frailty components such as psychological frailty. However, the strength of this recommendation is weak because of the low certainty/quality of the quantitative evidence, due to substantial study limitations, inconsistency and heterogeneity (different populations and interventions) as well as imprecision. Furthermore, the recommendation is meant to be conditional to the presence of factors shown to affect the acceptability and feasibility of such interventions and, hence, their success (Table 3).

Subgroup considerations.

Among the studies on physical interventions included in our systematic review [11], those that found significant benefits for frailty progression included participants belonging to a range of severities of frailty and ages. This was true for the different types of physical interventions considered here. On the other hand, it was suggested that a deficit status was necessary for interventions based on nutritional supplementation to effectively impact the level of frailty [31]. Even if some of the authors themselves supposed or perceived there to be an intervention window for physical transitions, this hypothesis was not systematically explored in any study. Additionally, without any specific analysis, it was impossible to separate the role of the severity of frailty on the effectiveness of the intervention from other possible correlated predictors. For example, in one study on exercise plus protein supplementation it was clearly shown that the initial level of frailty was associated with the level of compliance to the intervention [32].

R2 – We suggest implementing interventions based on tailored care and/or Geriatric Evaluation and Management (GEM), to prevent or delay the progression of frailty or to reverse frailty (conditional strength of recommendation). The recommendation is stronger for GEM-based interventions involving a multidisciplinary team, especially in inpatient clinical settings, but still conditional to the confirmation from further studies of good quality.

Justification.

We found some quantitative evidence for interventions based on a tailored care concept and/or on GEM being able to delay the progression of or revert frailty, as defined according to either a mainly physical paradigm or a multidomain paradigm. Some studies also reported on the impact of these interventions on frailty-related outcomes like functional ability, quality of life and hospitalisation (Additional file 2). Involvement of different professionals, a patient-centred approach, and delivering the intervention at a convenient location and/or in inpatient settings, seemed to be factors more likely associated with successful interventions, even though only limited head-to-head comparisons between interventions differing upon these aspects exist. Such types of interventions and, in particular, the presence of those factors, are also consistent with older people’s values and preferences as well as policy-makers’ idea of the direction towards which health systems should go, as collected through qualitative research [12,13,14] (Table 1). However, quantitative findings were not consistent across studies, even across similar studies, and studies had several methodological pitfalls. Therefore, no strong recommendations could be made.

Subgroup considerations.

It was difficult to reliably prove whether the level of frailty really acted as an effect modifier since, within studies, no subgroup analyses were systematically undertaken with this purpose. As a matter of fact, most of the interventions of this category that had positive significant effects on frailty were implemented in frail rather than prefrail populations.

R3 – We suggest considering interventions to prevent or delay the progression of frailty or to revert frailty, based on cognitive training, alone or in combination with exercise and nutritional supplementation (conditional strength of recommendation), and on exercise combined with diet consultation, at least in prefrail populations. At present, the panel does not suggest adopting interventions based on hormone therapy or on problem-solving therapy with the aim of preventing or delaying the progression of frailty or of reverting frailty (conditional strength of recommendation). Currently, there is no evidence in favour or against other interventions that could potentially be effective on frailty (e.g. other types of psychological interventions, interventions mainly focused on increasing socialisation, other types of hormone therapies, and pharmacological interventions).

Justification.

Interventions included in this last question were assessed separately because of their heterogeneity. Only one study per intervention was available. The panel judgment was mainly based on the quantitative results of these single studies and their quality, along with considerations regarding values, equity, acceptability and feasibility that could apply to each intervention separately. Thus, the evidence was judged as uncertain and the recommendations were made with weak strength, conditional to the confirmation from further studies.

Subgroup considerations.

All the studies relevant to this question were performed on a population definable as prefrail; therefore, no subgroup considerations could be made.

Discussion

Strengths of our work

This paper presents evidence- and consensus-based clinical guidelines on interventions to prevent or treat frailty, developed in the context of the FOCUS project. This was a core objective of the project, i.e. an ultimate deliverable in which the quantitative and qualitative research studies conducted in context of the project converged, and also represented the content of the service we intended to deliver in our proposal. To achieve such a pivotal objective, we required a solid methodological structure and the involvement of the entire FOCUS consortium to act as the guideline panel. We developed four guidelines based on one overarching question concerning interventions for frailty in general and three sub-questions on specific groups of interventions. Each guideline includes a recommendation on whether and how interventions should be implemented.

Our work has distinctive characteristics among other initiatives that have been undertaken to help clinicians and patients make informed decisions in the context of frailty. For instance, in 2015, the EIP-AHA – Action Group A3 produced a Decalogue on Frailty Prevention as a result of the work conducted by the group in the period 2012–2015, which includes ten key messages focusing on “the main areas of interest that policy makers at Member State level would need to support in order to tackle frailty” [33]. Before that, the British Geriatrics Society, in association with the Royal College of General Practitioners and Age UK, had published Fit for Frail, a comprehensive best practice guidance document for the care of older people living with frailty in community and outpatient settings [34]. Both of these initiatives are consensus-based guides that stemmed from the expertise and experience of the groups’ or societies’ members. Although these documents are useful and translate knowledge into action, they either did not start from a systematic appraisal of the evidence, or the process and evidence was not clearly documented and accessible. More recently, the results of a concurrent initiative – the Asia-Pacific Clinical Practice Guidelines for the Management of Frailty – have been published [35]. Starting from the presentations and discussions at the Asia-Pacific Geriatrics Conference on Geriatrics Beyond Borders: Are We Frailty Ready?, they performed a comprehensive and systematic review and adopted the GRADE approach to develop recommendations that span many aspects of the management of frailty. Two elements, inherent to the FOCUS mission, distinguish ours from these guidelines. First, we had the opportunity to use both quantitative and qualitative evidence in order to combine effect sizes with relevant stakeholders’ inputs and perspectives in the development of our guidelines, according to an integrated knowledge translation strategy. For these reasons, we adopted the EtD framework proposed by the GRADE working group, i.e. because of the relevance given to perspectives and subgroups, and the value assigned to criteria like values, acceptability, feasibility and equity. Secondly, not only did we have a narrower and deeper focus on interventions only, but we specifically reviewed and based our recommendations on interventional studies that explicitly looked at frailty as an outcome, excluding those studies in which interventions were applied to people with or at risk of frailty but assessed upon different outcomes. Although this may have led to the inclusion of a narrower evidence base, our approach intended to give frailty the dignity of a condition. Indeed, the role of frailty as a measurable outcome, and not only as a predictor, to evaluate the impact of interventions or of other types of exposures, has been increasingly recognised in different clinical settings [36, 37]. At the same time, within the selected studies, we did consider other outcomes, thus not overlooking or undervaluing the possibility that interventions can impact other important adverse events to which frail people are vulnerable.

Limitations

Our work has recognised limitations. The main limitation to the production of definitive guidelines was related to the quantitative evidence base. The evidence available was of low quality due to methodological bias, inconsistencies and imprecision in the existing studies. In addition to the low quality of the collected evidence, there was a high level of methodological heterogeneity, which had already prevented any quantitative synthesis in our systematic review [11]. The diversity of frailty definitions and operationalisations was mostly expected. It is also possible that our choice to include studies in our systematic review in which authors operationalised frailty using a study-specific, pre-specified set of indicators, while valuing the intention of the investigators, increased such heterogeneity. As a result of the heterogeneity and low quality of the collected evidence, which was often coupled with inadequate reporting, we were not able to draw the typical GRADE summary of findings or evidence profile tables [25]. The heterogeneous nature of interventions also represented a challenge to framing the guidelines into questions and grouping the interventions in an appropriate but also user-friendly manner. Finally, we encountered some technical limitations. Firstly, there were time constraints dictated by the FOCUS project timeline, which impeded the possibility of arranging a conference to facilitate the panel discussion. However, the discussion that took place online and by email achieved satisfactory results. Secondly, although extremely useful and user friendly, the EtD tool was limited in terms of flexibility to the development of guidelines for heterogeneous interventions in a field of complex nosography such as frailty in older age.

Lessons learned and future directions

The ultimate lesson we learned with our 3-year work is that, while stakeholders showed awareness of and place relevance to the challenge represented by age-related frailty, the current scientific quantitative evidence still has important limitations. This was reflected in our guidelines, which could include only weak or conditional recommendations. Even if such types of recommendations might seem less appealing or helpful, they do yield an important message to the clinician and decision-maker, i.e. to be considered when these interventions are adopted, or indeed, to give consideration to when and whether to adopt them. This message reflects the limitations of the scientific literature and important implementation considerations. Our work also conveys an important lesson to the researcher – while the evidence heterogeneity could never be eliminated since it reflects the heterogeneity in the definition of frailty itself, we need more studies which specifically recognise and measure frailty as an outcome as well as greater adherence to high methodological standards. This is true in general, but in particular for studies on comprehensive frailty interventions, which have the potential to be effective, especially when defined holistically, and have so far not been adequately evaluated. We also need more studies to compare different interventions. The fact that most of the studies included in our evidence base compared the experimental intervention with ‘usual practice’, which can differ dramatically from reality to reality, made the findings extremely context bound. This generated the need to include, in our guidelines, not only an answer to the question ‘does it work?’ but also a consideration of the circumstances of success.

Conclusion

Herein, we delivered evidence- and consensus-based guidelines on interventions that can affect frailty as an outcome. We recognised that these are not conclusive; rather, they should foster further studies, both on those interventions already investigated in the literature but requiring higher research standards as well as on potentially effective interventions that have not been appropriately studied thus far. On the other hand, our recommendations should start informing practices. In the context of the FOCUS project, we ended our project by testing the feasibility and impact of our guidelines when used to inform clinical decisions and help implement or refine interventions addressing frailty as a patient-important outcome; the results of these proof-of-concept pilots are currently in preparation for publication [38].

Availability of data and materials

Not applicable.

Abbreviations

EIP-AHA European:

European Innovation Partnership on Active and Healthy Ageing,

EtD:

Evidence-to-decision

FOCUS:

Frailty management optimisation through EIP-AHA commitments and utilisation of stakeholders input

GEM:

Geriatric evaluation and management

GRADE:

Grading of recommendations assessment, development and evaluation

iEtD:

interactive EtD

References

  1. 1.

    Fried LP. Frailty. In: Hazzard WR, Bierman EL, Blass JP, Ettinger Jr WH, Halter JB, editors. Principles of geriatric medicine and gerontology. 3rd ed. New York: McGraw-Hill; 1994. p. 1149–55.

  2. 2.

    Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146.

  3. 3.

    Walston J, Hadley EC, Ferrucci L, et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging research conference on frailty in older adults. J Am Geriatr Soc. 2006;54:991.

  4. 4.

    Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci. 2007;62:722–7.

  5. 5.

    Cigolle CT, Ofstedal MB, Tian Z, et al. Comparing models of frailty: the health and retirement study. J Am Ger Soc. 2009;57:830–9.

  6. 6.

    Theou O, Brothers TD, Mitnitski A, et al. Operationalization of frailty using eight commonly used scales and comparison of their ability to predict all-cause mortality. J Am Geriatr Soc. 2013;61:1537–51.

  7. 7.

    Hamerman D. Toward an understanding of frailty. Ann Intern Med. 1999;130:945–50.

  8. 8.

    Cano A, Kurpas D, Bujnowska-Fedak MM, et al. FOCUS: frailty management optimisation through EIPAHA commitments and utilisation of stakeholders’ input – an innovative European project in elderly care. Fam Med Primary Care Rev. 2016;18:373–6.

  9. 9.

    FOCUS website. http://focus-aha.eu/home. Accessed 1 Nov 2018.

  10. 10.

    Apóstolo J, Cooke R, Bobrowicz-Campos E, et al. Predicting risk and outcomes for frail older adults: an umbrella review of frailty screening tools. JBI Database System Rev Implement Rep. 2017;15:1154–208.

  11. 11.

    Apostolo J, Cooke R, Bobrowicz-Campos E, et al. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep. 2018;16:140–232.

  12. 12.

    D'Avanzo B, Shaw R, Riva S, et al. Stakeholders’ views and experiences of care and interventions for addressing frailty and pre-frailty: a meta-synthesis of qualitative evidence. PLoS One. 2017;12:e0180127.

  13. 13.

    Shaw RL, Gwyther H, Holland C, et al. Understanding frailty: meanings and beliefs about screening and prevention across key stakeholder groups in Europe. Ageing Soc. 2018;38(6):1223–52.

  14. 14.

    Gwyther H, Shaw R, Bobrowicz-Campos B, et al. Understanding frailty: a qualitative study of European healthcare policy-makers’ approaches to frailty screening and management. BMJ Open. 2018;8:e018653.

  15. 15.

    Gwyther H, Cooke R, Shaw R, et al. Perceptions and experiences of frailty interventions: quantitative and qualitative results from a survey of partners within the European innovation partnership on active and healthy ageing (EIP-AHA). Ageing Soc. 2018;38(9):1843–67.

  16. 16.

    Gwyther H, Bobrowicz-Campos B, Apostolo J, et al. A realist review to understand the efficacy and outcomes of European frailty interventions in the country, healthcare organisational and patient contexts. Health Psychol Rev. 2018;12:382–404.

  17. 17.

    Guidelines for WHO Guidelines. Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland. Version: 10 March 2003. http://apps.who.int/iris/bitstream/10665/68925/1/EIP_GPE_EQC_2003_1.pdf. Accessed 9 Mar 2019.

  18. 18.

    Clinical practice guidelines we can trust/Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, Institute of Medicine of the National Academies; Robin Graham et al. editors. Washington, DC: National Academies Press; 2011.

  19. 19.

    Rich MW, Chyun DA, Skolnick AH, et al. Knowledge gaps in cardiovascular care of older adults: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society: executive summary. J Am Geriatr Soc. 2016;64:2185–92.

  20. 20.

    Tazkarji B, Lam R, Lee S, et al. Approach to preventive care in the elderly. Can Fam Physician. 2016;62:717–21.

  21. 21.

    Droz JP, Aapro M, Balducci L, et al. Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. Lancet Oncol. 2014;15:e404–14.

  22. 22.

    Mallery LH, Ransom T, Steeves B, et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the diabetes care program of Nova Scotia (DCPNS) and the palliative and therapeutic harmonization (PATH) program. J Am Med Dir Assoc. 2013;14:801–8.

  23. 23.

    Neumann I, Brignardello-Petersen R, Wiercioch W, et al. The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels. Implement Sci. 2016;11:93.

  24. 24.

    Richardson WS, Wilson MC, Nishikawa J, Hayward RS. The well-built clinical question: a key to evidence-based decisions. ACP J Club. 1995;123:A12–3.

  25. 25.

    Guyatt G, Oxman AD, Aklet EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383e394.

  26. 26.

    Guyatt GH, Oxman AD, Kunz R, et al. GRADE working group. Going from evidence to recommendations. BMJ. 2008;336:1049–51.

  27. 27.

    Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. BMJ. 2016;353:i2016.

  28. 28.

    GRADE-DECIDE. Interactive Evidence to Decision frameworks website https://ietd.epistemonikos.org/#/login. Accessed 24 Apr 2019.

  29. 29.

    Wong G, Westhorp G, Pawson R, Greenhalgh T. Realist synthesis: RAMESES training materials. London: The RAMESES Project; 2013.

  30. 30.

    European Innovation Partnership on Active and Healthy Aging https://ec.europa.eu/eip/ageing/home_en. Accessed 7 Nov 2018.

  31. 31.

    Kim CO, Lee KR. Preventive effect of protein-energy supplementation on the functional decline of frail older adults with low socioeconomic status: a community-based randomized controlled study. J Gerontol A Biol Sci Med Sci. 2013;68:309–16.

  32. 32.

    Bonnefoy M, Boutitie F, Mercier C, et al. Efficacy of a home-based intervention programme on the physical activity level and functional ability of older people using domestic services: a randomised study. J Nutr Health Aging. 2012;16:370–7.

  33. 33.

    Building European Commitment to Prevent and Tackle Frailty. A Decalogue on Frailty Prevention 2015. Part of the European Innovation Partnership on Active and Healthy Ageing. https://ec.europa.eu/research/innovation-union/pdf/active-healthy-ageing/a3_decalogue_2015.pdf. Accessed 7 Nov 2018.

  34. 34.

    Fit for Frailty. Consensus Best Practice Guidance for the Care of Older People Living in Community and Outpatient Settings. A Report by the British Geriatrics Society in Association with the Royal College of General Practitioners and Age UK. http://www.bgs.org.uk/index.php/fit-for-frailty. Accessed 1 Dec 2017.

  35. 35.

    Dent E, Lien C, Lim WS, et al. The Asia-Pacific clinical practice guidelines for the Management of Frailty. J Am Med Dir Assoc. 2017;18:564–75.

  36. 36.

    Ogawa M, Izawa KP, Satomi-Kobayashi S, et al. Impact of delirium on postoperative frailty and long term cardiovascular events after cardiac surgery. PLoS One. 2017;12:e0190359.

  37. 37.

    Kim DH, Afilalo J, Shi SM, et al. Evaluation of changes in functional status in the year after aortic valve replacement. JAMA Intern Med. 2019;179(3):383–91.

  38. 38.

    Damanti S, Azzolino D, Riva S, Cano A, Marcucci M. FOCUS Project collaborators. PoliFIT-INFOcus: a pilot study exploring how to promote physical activity in older people. Eur J Intern Med. 2018;57:e41–2.

Download references

Acknowledgements

The authors thank Holger Shünemann, MD, PhD, Professor at the Department of Health Research Methods, Evidence, and Impact at McMaster University, and Director of McMaster GRADE Centre, Hamilton, ON, for the material and advice to support the application to our work of the GRADE methods. They also thank Sarah Rosembaum, PhD, Centre for Informed Health Choices, Oslo, Norway, for the technical help with the iEtD tool.

Funding

This work was part of a larger study, ‘Frailty Management Optimisation through EIP-AHA Commitments and Utilisation of Stakeholders Input’ [Grant number 664367 FOCUS], supported by the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) of the European Commission, under the European Union Health Programme (2014–2020).

Author information

All authors made substantial contributions to this research paper in accordance with ICMJE requirements. MM, CH and AC conceived the research idea. MM designed the study. MM, SD and FG drafted the manuscript. All authors revised and approved the article prior to submission. AC was the guarantor.

Correspondence to Maura Marcucci.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

All authors declare that this study is part of the project/joint action ‘664367/FOCUS’, which has received funding from the European Union’s Health Programme (2014–2020) and Ministry of Science and Higher Education in Poland (funding in years 2015–2018 allocated for the international co-financed project); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; and no other relationships or activities that could appear to have influenced the submitted work. All authors fulfilled the conditions required for authorship and the final manuscript has been seen and approved by all authors. The funding body did not have any influence on the content of the guidelines.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Additional file 1. Synthesis of quantitative evidence from the FOCUS systematic review [9], showing the effect of the interventions on frailty as an outcome, adapted from the typical GRADE Summary of Findings table structure, as offered to the guideline panellists.

Additional file 2. Narrative synthesis of the effect of interventions on secondary outcomes, as offered to the guideline panellists.

Additional file 3: Table S1. Table that describes the members of the FOCUS Guideline Panel and their role in the development of the guidelines.

Additional file 4. Example of the output of the voting process using the Evidence to Decision template, as received and processed by the guidelines technical team.

Additional file 5. Detailed justification for the judgement upon each Evidence to Decision criterion, for each guideline.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Marcucci, M., Damanti, S., Germini, F. et al. Interventions to prevent, delay or reverse frailty in older people: a journey towards clinical guidelines. BMC Med 17, 193 (2019) doi:10.1186/s12916-019-1434-2

Download citation

Keywords

  • Frailty
  • Older people
  • Interventions
  • Guidelines
  • Decision-making
  • Implementation
  • GRADE system